LEPU BIO-B: The China Securities Regulatory Commission issued a filing notice to the company regarding the application for full circulation of H shares

LEPU BIO-B announced that it has submitted an H-share full circulation filing application to the China Securities Regulatory Commission, involving the conversion of 54.2684 million domestic unlisted shares into H-shares for listing on the Hong Kong Stock Exchange. The China Securities Regulatory Commission issued a filing notice on May 26, 2025, and the filing has been completed. If the conversion and listing are not completed within 12 months, the filing materials need to be updated. The specific implementation plan has not yet been finalized and must go through relevant procedures before completion. The company will announce progress in a timely manner